HomeNKTR • NASDAQ
Nektar Therapeutics
add
$25.01
0.36%
Pre-market:(0.32%)-0.080
$24.93
Closed: Jul 14, 4:19:42 AM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 10.46M | -51.66% |
Operating expense | 54.83M | 15.28% |
Net income | -50.88M | -38.26% |
Net profit margin | -486.44 | -186.02% |
Earnings per share | -3.61 | -30.65% |
EBITDA | -43.94M | -33.78% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 218.63M | -24.41% |
Total assets | 256.24M | -35.29% |
Total liabilities | 242.50M | -9.95% |
Total equity | 13.74M | — |
Shares outstanding | 12.41M | — |
Price to book | 22.61 | — |
Return on assets | -39.61% | — |
Return on capital | -48.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -50.88M | -38.26% |
Cash from operations | -49.05M | -2.43% |
Cash from investing | 43.69M | 126.86% |
Cash from financing | 7.00K | -99.98% |
Net change in cash | -5.36M | -140.09% |
Free cash flow | -24.17M | -20.73% |
Previous close
$25.10
Day range
$23.86 - $26.29
Year range
$6.50 - $37.38
Market cap
416.74M USD
Avg Volume
3.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1990
Headquarters
Website
Employees
61
